New release delivers faster asset discovery, breakthrough segmentation performance, expanded visibility, and a ...

In the heart of winter, with cold mornings and evenings, and limited sunlight, the desire to stay out on long runs (or leave ...

In Silicon Valley's new productivity regime, it is no longer enough to hit your goals. You now have to document, quantify, ...

As the Monitor begins our 118th year of publication, our new leadership team is going back to our founding documents.

US President Donald Trump has warned European nations they could face new tariffs if they oppose his plans for Greenland. The ...

Samuel Miller McDonald unpacks centuries of conquest and expansion in “Progress: How One Idea Built Civilization and Now ...

Myanmar’s military-backed party has extended its lead after the second round of voting in the country's election, according ...

As of, 2026, California’s AB 325 fundamentally reshapes the legal landscape for algorithmic pricing. By explicitly ...

Small brick-and-mortar businesses in the Seattle area say they're under more financial stress today than they were during the height of the COVID-19 pandemic, according to a new survey.

Opinion: The Department of Justice's settlement with RealPage argues that the use of algorithmic pricing software itself ...

The stock option awards were granted outside of the Context Therapeutics Inc. 2021 Long-Term Performance Incentive Plan in accordance with Nasdaq Listing Rule 5635 (c) (4).

The notification letter has no immediate effect on the listing of the Company’s class A ordinary shares, which will continue to trade uninterrupted on Nasdaq under the ticker “HKPD”.